Korean Guidelines for the Diagnosis and Management of Dry Eye: Development and Validation of Clinical Efficacy
2
조회
0
다운로드
30
인용
0
참고문헌
키워드
초록
Purpose: To evaluate the clinical efficacy of newly developed guidelines for the diagnosis and management ofdry eye. Methods: This retrospective, multi-center, non-randomized, observational study included a total of 1,612 patientswith dry eye disease who initially visited the clinics from March 2010 to August 2010. Korean guidelinesfor the diagnosis and management of dry eye were newly developed from concise, expert-consensus recommendations. Severity levels at initial and final visits were determined using the guidelines in patients with 90± 7 days of follow-up visits (n = 526). Groups with different clinical outcomes were compared with respect toclinical parameters, treatment modalities, and guideline compliance. Main outcome measures were ocular andvisual symptoms, ocular surface disease index, global assessment by patient and physician, tear film break-uptime, Schirmer-1 test score, ocular surface staining score at initial and final visits, clinical outcome after threemonths of treatment, and guideline compliance. Results: Severity level was reduced in 47.37% of patients treated as recommended by the guidelines. Youngerage (odd ratio [OR], 0.984; p = 0.044), higher severity level at initial visit, compliance to treatment recommendation(OR, 1.832; p = 0.047), and use of topical cyclosporine (OR, 1.838; p = 0.011) were significantly associatedwith improved clinical outcomes. Conclusions: Korean guidelines for the diagnosis and management of dry eye can be used as a valid and effectivetool for the treatment of dry eye disease.
Abstract
Purpose: To evaluate the clinical efficacy of newly developed guidelines for the diagnosis and management ofdry eye. Methods: This retrospective, multi-center, non-randomized, observational study included a total of 1,612 patientswith dry eye disease who initially visited the clinics from March 2010 to August 2010. Korean guidelinesfor the diagnosis and management of dry eye were newly developed from concise, expert-consensus recommendations. Severity levels at initial and final visits were determined using the guidelines in patients with 90± 7 days of follow-up visits (n = 526). Groups with different clinical outcomes were compared with respect toclinical parameters, treatment modalities, and guideline compliance. Main outcome measures were ocular andvisual symptoms, ocular surface disease index, global assessment by patient and physician, tear film break-uptime, Schirmer-1 test score, ocular surface staining score at initial and final visits, clinical outcome after threemonths of treatment, and guideline compliance. Results: Severity level was reduced in 47.37% of patients treated as recommended by the guidelines. Youngerage (odd ratio [OR], 0.984; p = 0.044), higher severity level at initial visit, compliance to treatment recommendation(OR, 1.832; p = 0.047), and use of topical cyclosporine (OR, 1.838; p = 0.011) were significantly associatedwith improved clinical outcomes. Conclusions: Korean guidelines for the diagnosis and management of dry eye can be used as a valid and effectivetool for the treatment of dry eye disease.
참고문헌 (17)
- Lemp MA, "Report of the National Eye Institute", Industry workshop on clinical trials in dry eyes, 1995, pp.21, 221~232
- Behrens A, "Dysfunctional tear syndrome:a Delphi approach to treatment recommendations", Cornea, 25, pp.900~907 (2006)
- "The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007)", Ocul Surf, 5, pp.75~92 (2007)
- "Methodologies to diagnose and monitor dry eye disease:report of the Diagnostic Methodology Subcommittee of the International Dry Eye WorkShop (2007)", Ocul Surf, 5, pp.108~152 (2007)
- Han SB, "Prevalence of dry eye disease in an elderly Korean population", Arch Ophthalmol, 129, pp.633~638 (2011)
- "The epidemiology of dry eye disease: report of the Epidemiology Subcommittee of the International Dry Eye Work-Shop (2007)", Ocul Surf, 5, pp.93~107 (2007)
- Nichols KK, "The lack of association between signs and symptoms in patients with dry eye disease", Cornea, 23, pp.762~770 (2004)
- Nichols KK, "Association of clinical diagnostic tests and dry eye surveys: the NEI-VFQ-25 and the OSDI", Adv Exp Med Biol, 506(Pt B), pp.1177~1181 (2002)
- Bron AJ, "Grading of corneal and conjunctival staining in the context of other dry eye tests", Cornea, 22, pp.640~650 (2003)
- Schiffman RM, "Reliability and validity of the Ocular Surface Disease Index", Arch Ophthalmol, 118, pp.615~621 (2000)
- Nelson JD, "The international workshop on meibomian gland dysfunction:report of the definition and classification subcommittee", Invest Ophthalmol Vis Sci, 52, pp.1930~1937 (2011)
- Wilson SE, "Agreement of physician treatment practices with the international task force guidelines for diagnosis and treatment of dry eye disease", Cornea, 26, pp.284~289 (2007)
- Perry HD, "Evaluation of topical cyclosporine for the treatment of dry eye disease", Arch Ophthalmol, 126, pp.1046~1050 (2008)
- "Management and therapy of dry eye disease: report of the Management and Therapy Subcommittee of the International Dry Eye WorkShop (2007)", Ocul Surf, 5, pp.163~178 (2007)
- Baiza-Duran L, "A comparative clinical trial of the efficacy of two different aqueous solutions of cyclosporine for the treatment of moderate-to-severe dry eye syndrome", Br J Ophthalmol, 94, pp.1312~1315 (2010)
- Barber LD, "Phase III safety evaluation of cyclosporine 0.1% ophthalmic emulsion administered twice daily to dry eye disease patients for up to 3 years", Ophthalmology, 112, pp.1790~1794 (2005)
- Sall K, "Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 Study Group", Ophthalmology, 107, pp.631~639 (2000)